期刊
JOURNAL OF MOLECULAR ENDOCRINOLOGY
卷 61, 期 4, 页码 173-184出版社
BIOSCIENTIFICA LTD
DOI: 10.1530/JME-18-0078
关键词
macrophages; Pentraxin3; obesity; interleukin 10; metabolic syndrome
资金
- Faculty of Medicine and Health Sciences (Early career research grant), Stellenbosch University
- South African Medical Research Council (SAMRC) under a Self-Initiated Research Grant
- SAMRC
- Faculty of Medicine and Health Sciences, Stellenbosch University
Obesity-associated inflammatory mechanisms play a key role in the pathogenesis of metabolic-related diseases. Failure of anti-inflammatory control mechanisms within adipose tissue and peripheral blood mononuclear cells (PBMCs) have been implicated in disease progression. This study investigated the efficacy of allogeneic adipose tissue-derived mesenchymal stem cells conditioned media (ADSC-CM) to counteract persistent inflammation by inducing an anti-inflammatory phenotype and cytokine response within PBMCs derived from patients with and without metabolic syndrome. Forty-six (n=46) mixed ancestry females (18-45 years) were subdivided into (a) healthy lean (HL) (n=10) (BMI <25 kg/m(2)), (b) overweight/obese (OW/OB) (BMI >= 25 kg/m(2), <3 metabolic risk factors) (n=22) and (c) metabolic syndrome (MetS) (visceral adiposity, >= 3 metabolic risk factors) (n=14) groups. Body composition (DXA scan), metabolic (cholesterol, HDL, LDL, triglycerides, blood glucose) and inflammatory profiles (38-Plex cytokine panel) were determined. PBMCs were isolated from whole blood and treated ex vivo with either (i) autologous participant-derived serum, (ii) ADSCs-CM or (iii) a successive treatment regime. The activation status (CD11b+) and intracellular cytokine (IL6, IL10, TNFa) expression were determined in M1 (CD68+CD206-CD163-) and M2 (CD68+CD163+ CD206+) macrophage populations using flow cytometry. ADSC-CM treatment, promoted a M2 macrophage phenotype and induced IL10 expression, this was most pronounced in the OW/OB group. This response is likely mediated by multiple complementing factors within ADSC-CM, yet to be identified. This study is the first to demonstrate the therapeutic potential of ADSC-CM to restore the inflammatory balance in immune compromised obese individuals.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据